Navigation Links
Pfizer inks global license to Genomatix Software and databases
Date:7/15/2008

Genomatix Software, Inc. the US branch of Munich (Germany) based Genomatix Software GmbH, announced that it has reached an agreement with Pfizer Pharmaceuticals to provide Genomatix software and data content to Pfizer sites across the globe. The Genomatix tools licensed by Pfizer are designed to show how genes are regulated at a molecular level, and Pfizer scientists will use the software and data content to help understand the molecular basis of how their potential drug targets may be co-regulated with other important targets, producing potential desirable or unwanted side-effects.

"Adding Genomatix to Pfizers existing genomics software capabilities was a natural choice." said Peter Grant, CEO of Genomatix Software, Inc. "Our broad set of capabilities are a good compliment to those that Pfizer already has in house. We are pleased to be a part of Pfizer's significant effort in molecular genomics. We believe our tools will provide a great value to their research effort, but the proof is always in the results. Now the fun really begins!" he concluded.


'/>"/>

Contact: Jacqueline Lamont
lamont@genomatix-software.com
877-436-6628
Genomatix Software GmbH
Source:Eurekalert

Page: 1

Related biology news :

1. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
2. Duckweed genome sequencing has global implications
3. Ancient oak trees help reduce global warming
4. Global Challenges/Chemistry Solutions debuts with focus on drinking water
5. Ecological globalization
6. Baker Institute study, conference weigh risks for global energy markets
7. Warming climate is changing life on global scale, says new study
8. 65-million-year-old asteroid impact triggered a global hail of carbon beads
9. Global warming linked to caribou-calf mortality
10. Scientists to explore global change-public health connection
11. FISH-BOL: NOAA researchers help build a global reference library of DNA barcodes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: